NEOCREATE
08 Dec 2020
NEOCREATE
ACTRN12619000288123
Neoadjuvant Immune-Chemo-Radiotherapy in operable oEsophageal and gastro-oesophageal junction cancers with Carboplatin Paclitaxel Radiotherapy and Avelumab – a Trial assessing feasibility and preliminary Efficacy
SA HEALTH
Cancer Type | Stomach & Oesophageal |
---|---|
Trial Type | Treatment |
Phase | Phase II |
Age Range | 18 years and older |
Sex | Both |
Tumour Stream | oesophageal/ gastro-oesophageal junction (GOJ) adenocarcinoma |
Cancer Stage | Early\In Situ |
Anticipated Start Date | 2019-05-31 |
Anticipated End Date | - |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alex Scott-Hoy |
alex.scott-hoy@sa.gov.au | |
Phone | 08 8204 4830 |
Principal Investigator | Dr Amitesh Roy |
Recruitment Status | Recruiting |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Dr Nimit Singhal |
Recruitment Status | Recruiting |
Hospital | Lyell McEwin hospital |
---|---|
Clinical Trial Coordinator | Andy Phay |
andy.phay@sa.gov.au | |
Phone | 08 8282 0833 |
Principal Investigator | Dr Nimit Singhal |
Recruitment Status | Recruiting |